Product Code: PM4926
The global clinical nutrition for cancer care market size is expected to reach USD 7.11 billion by 2032, according to a new study by Polaris Market Research. The report "Clinical Nutrition for Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Type (Oral Nutrition, Parenteral Nutrition, and Enteral Feeding Formulas); By Cancer Type; By Age Group; By Sales Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The ability of nutritional support products to improve the immunity of cancer patients by providing the required amount of nutrients is primarily responsible for the market growth. Moreover, the implementation of strategic initiatives such as new product launches, merges, acquisitions, alliance, and partnerships contribute to the market growth. For instance, in January 2024, Danone Nutricia announced a new partnership with Resilience to develop nutritional support module for patients with cancer. Such strategic initiatives will make nutrition an integral part of oncology treatment in the coming years.
Sedentary lifestyle, lack of physical activity, and inheritance are some of main causes of cancer. Growing prevalence of cancer disease, increasing incidence of malnourishment among cancer patients, improving infrastructure of cancer care centers, and rising hospital admissions for the treatment of various types of cancer are some of the major factors responsible for the growth of clinical nutrition for cancer care market. For instance, according as per the fact & figures published by the World Health Organization (WHO), in 2022, an estimated 20 million new cancer cases were reported in 115 countries across the world.
High demand for personalized treatment, rising need to assess nutritional status during cancer therapy, and the advent of effective nutritional supplements with better treatment outcomes are expected to contribute to the market during the forecast period. Moreover, the necessity to modify the immune system among the cancer patients receiving immune-oncology treatment will increase the demand for nutritional supplements for cancer. Furthermore, rising focus of manufacturers towards educating healthcare practitioners on cancer nutrition as a complementary treatment will boost the market growth in the upcoming years.
Clinical Nutrition for Cancer Care Market Report Highlights
The oral nutrition segment dominated the market, owing to the benefits such as ease of consumption and convenience offered by oral supplements to cancer patients.
The lung cancer segment is expected to expand at the significant CAGR, owing to the high prevalence of lung cancer in the developed countries.
The adults segment dominated the global market in 2023, owing to increasing occurrence rate of malnourishment among adult cancer patients.
The online segment is anticipated to register the highest CAGR, owing to the increasing preference to online distribution.
North America held the largest market share, owing to the high prevalence of cancer patients and rising need for assessment of nutritional status before cancer therapy.
The market players include Nestle Health Science, Abbott Nutrition, Danone Nutricia, Bayer AG, and Baxter among others.
Polaris Market Research has segmented the clinical nutrition for cancer care market report based on and region:
Clinical Nutrition for Cancer Care, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Oral Nutrition
- Parenteral Nutrition
- Enteral Feeding Formulas
Clinical Nutrition for Cancer Care, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Head & Neck Cancer
- Stomach & Gastrointestinal Cancers
- Blood Cancer
- Breast Cancer
- Lung Cancer
- Others
Clinical Nutrition for Cancer Care, Age Group Outlook (Revenue - USD Billion, 2019 - 2032)
Clinical Nutrition for Cancer Care, Sales Channel Outlook (Revenue - USD Billion, 2019 - 2032)
Clinical Nutrition for Cancer Care, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Clinical Nutrition for Cancer Care Market Insights
- 4.1. Clinical Nutrition for Cancer Care - Industry Snapshot
- 4.2. Clinical Nutrition for Cancer Care Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing cancer burden and rising risk of malnutrition in oncology patients are driving the market growth
- 4.2.1.2. Potential benefits of nutrition in cancer treatment will prove beneficial for the market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of clinical evidence in oncology nutrition limits the expansion of clinical nutrition for cancer care market
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Clinical Nutrition for Cancer Care Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Clinical Nutrition for Cancer Care Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 5.3. Oral Nutrition
- 5.3.1. Global Clinical Nutrition for Cancer Care Market, by Oral Nutrition, by Region, 2019-2032 (USD Billion)
- 5.4. Parenteral Nutrition
- 5.4.1. Global Clinical Nutrition for Cancer Care Market, by Parenteral Nutrition, by Region, 2019-2032 (USD Billion)
- 5.5. Enteral Feeding Formulas
- 5.5.1. Global Clinical Nutrition for Cancer Care Market, by Enteral Feeding Formulas, by Region, 2019-2032 (USD Billion)
6. Global Clinical Nutrition for Cancer Care Market, by Cancer Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 6.3. Head & Neck Cancer
- 6.3.1. Global Clinical Nutrition for Cancer Care Market, by Head & Neck Cancer, by Region, 2019-2032 (USD Billion)
- 6.4. Stomach & Gastrointestinal Cancers
- 6.4.1. Global Clinical Nutrition for Cancer Care Market, by Stomach & Gastrointestinal Cancers, by Region, 2019-2032 (USD Billion)
- 6.5. Blood Cancer
- 6.5.1. Global Clinical Nutrition for Cancer Care Market, by Blood Cancer, by Region, 2019-2032 (USD Billion)
- 6.6. Breast Cancer
- 6.6.1. Global Clinical Nutrition for Cancer Care Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
- 6.7. Lung Cancer
- 6.7.1. Global Clinical Nutrition for Cancer Care Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
- 6.8. Others
- 6.8.1. Global Clinical Nutrition for Cancer Care Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Clinical Nutrition for Cancer Care Market, by Age Group
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 7.3. Adult
- 7.3.1. Global Clinical Nutrition for Cancer Care Market, by Adult, by Region, 2019-2032 (USD Billion)
- 7.4. Paediatric
- 7.4.1. Global Clinical Nutrition for Cancer Care Market, by Paediatric, by Region, 2019-2032 (USD Billion)
8. Global Clinical Nutrition for Cancer Care Market, by Sales Channel
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 8.3. Offline
- 8.3.1. Global Clinical Nutrition for Cancer Care Market, by Offline, by Region, 2019-2032 (USD Billion)
- 8.4. Online
- 8.4.1. Global Clinical Nutrition for Cancer Care Market, by Online, by Region, 2019-2032 (USD Billion)
9. Global Clinical Nutrition for Cancer Care Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Clinical Nutrition for Cancer Care Market Assessment, By Geography, 2019-2032 (USD Billion)
- 9.3. Clinical Nutrition for Cancer Care Market - North America
- 9.3.1. North America: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.3.2. North America: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.3.3. North America: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.3.4. North America: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.3.5. Clinical Nutrition for Cancer Care Market - U.S.
- 9.3.5.1. U.S.: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.3.5.2. U.S.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.3.5.3. U.S.: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.3.5.4. U.S.: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.3.6. Clinical Nutrition for Cancer Care Market - Canada
- 9.3.6.1. Canada: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.3.6.2. Canada: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.3.6.3. Canada: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.3.6.4. Canada: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4. Clinical Nutrition for Cancer Care Market - Europe
- 9.4.1. Europe: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.2. Europe: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.3. Europe: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.4. Europe: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.5. Clinical Nutrition for Cancer Care Market - UK
- 9.4.5.1. UK: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.5.2. UK: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.5.3. UK: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.5.4. UK: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.6. Clinical Nutrition for Cancer Care Market - France
- 9.4.6.1. France: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.6.2. France: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.6.3. France: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.6.4. France: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.7. Clinical Nutrition for Cancer Care Market - Germany
- 9.4.7.1. Germany: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.7.2. Germany: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.7.3. Germany: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.7.4. Germany: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.8. Clinical Nutrition for Cancer Care Market - Italy
- 9.4.8.1. Italy: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.8.2. Italy: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.8.3. Italy: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.8.4. Italy: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.9. Clinical Nutrition for Cancer Care Market - Spain
- 9.4.9.1. Spain: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.9.2. Spain: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.9.3. Spain: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.9.4. Spain: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.10. Clinical Nutrition for Cancer Care Market - Netherlands
- 9.4.10.1. Netherlands: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.10.2. Netherlands: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.10.3. Netherlands: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.10.4. Netherlands: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.11. Clinical Nutrition for Cancer Care Market - Russia
- 9.4.11.1. Russia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.11.2. Russia.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.11.3. Russia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.11.4. Russia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5. Clinical Nutrition for Cancer Care Market - Asia Pacific
- 9.5.1. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.5. Clinical Nutrition for Cancer Care Market - China
- 9.5.5.1. China: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.5.2. China.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.5.3. China: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.5.4. China: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.6. Clinical Nutrition for Cancer Care Market - India
- 9.5.6.1. India: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.6.2. India.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.6.3. India: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.6.4. India: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.7. Clinical Nutrition for Cancer Care Market - Japan
- 9.5.7.1. Japan: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.7.2. Japan.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.7.3. Japan: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.7.4. Japan: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.8. Clinical Nutrition for Cancer Care Market - Malaysia
- 9.5.8.1. Malaysia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.8.2. Malaysia.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.8.3. Malaysia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.8.4. Malaysia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.9. Clinical Nutrition for Cancer Care Market - Indonesia
- 9.5.9.1. Indonesia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.9.2. Indonesia.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.9.3. Indonesia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.9.4. Indonesia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.10. Clinical Nutrition for Cancer Care Market - South Korea
- 9.5.10.1. South Korea: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.10.2. South Korea.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.10.3. South Korea: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.10.4. South Korea: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6. Clinical Nutrition for Cancer Care Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.5. Clinical Nutrition for Cancer Care Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.5.2. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.5.3. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.5.4. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.6. Clinical Nutrition for Cancer Care Market - South Africa
- 9.6.6.1. South Africa: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.6.2. South Africa: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.6.3. South Africa: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.6.4. South Africa: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.7. Clinical Nutrition for Cancer Care Market - Israel
- 9.6.7.1. Israel: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.7.2. Israel: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.7.3. Israel: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.7.4. Israel: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.8. Clinical Nutrition for Cancer Care Market - UAE
- 9.6.8.1. UAE: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.8.2. UAE: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.8.3. UAE: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.8.4. UAE: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.7. Clinical Nutrition for Cancer Care Market - Latin America
- 9.7.1. Latin America: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.7.5. Clinical Nutrition for Cancer Care Market - Mexico
- 9.7.5.1. Mexico: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.7.5.2. Mexico: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.7.5.3. Mexico: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.7.5.4. Mexico: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.7.6. Clinical Nutrition for Cancer Care Market - Brazil
- 9.7.6.1. Brazil: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.7.6.2. Brazil: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.7.6.3. Brazil: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.7.6.4. Brazil: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.7.7. Clinical Nutrition for Cancer Care Market - Argentina
- 9.7.7.1. Argentina: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.7.7.2. Argentina: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.7.7.3. Argentina: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.7.7.4. Argentina: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abbott Nutrition (U.S.)
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Baxter (U.S.)
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Bayer AG (Germany)
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Danone Nutricia (The Netherlands)
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. GlaxoSmithKline plc (UK)
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Medtrition, Inc. (U.S.)
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Nestle Health Science (Switzerland)
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Otsuka Holdings Co., Ltd. (Japan)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Pfizer Inc. (U.S.)
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Victus, Inc. (U.S.)
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development